Home ceftriaxone n (%) | Hospital flucloxacillin n (%) | OR (95% CI) for home treatment Univariate* | OR (95% CI) for home treatment Multivariate | |
Demographics | ||||
Total patients | 47 (41) | 68 (59) | ||
Female | 21 (45) | 30 (44) | 1.02 (0.48 to 2.16) | 0.73 (0.28 to 1.92) |
Age (year), mean±SD | 6.3±4.8 | 6.3±4.3 | 0.50 | 0.95 (0.85 to 1.06) |
Clinical features | ||||
Site | ||||
Periorbital | 9 (19) | 22 (32) | 0.50 (0.20 to1.20) | 1.04 (0.30 to 3.59) |
Lower limb | 27 (57) | 20 (29) | 3.24 (1.49 to 7.06) | 3.91 (1.24 to 12.30) |
Upper limb | 8 (17) | 13 (19) | 0.87 (0.33 to 2.29) | |
Head and neck | 2 (4) | 7 (10) | 0.39 (0.08 to 1.95) | |
Trunk and abdomen | 3 (6) | 8 (12) | 0.51 (0.13 to 2.04) | |
Prior oral antibiotics | 26 (55) | 38 (56) | 0.98 (0.46 to 2.07) | 1.01 (0.38 to 2.68) |
Systemic symptoms | 15 (32) | 24 (33) | 0.86 (0.39 to 1.59) | 1.60 (0.60 to 4.26) |
Percentage body surface area affected, median (IQR) | 0.47 (0.17–1.45) | 0.23 (0.13–0.95) | 0.13 | 0.99 (0.74 to 1.33) |
Reasons cited for intravenous antibiotics | ||||
Failed oral antibiotics | 17 (36) | 19 (28) | 1.46 (0.66 to 3.24) | |
Clinical features | ||||
Rapid spreading/significant swelling | 12 (26) | 18 (26) | 0.95 (0.41 to 2.22) | |
Thrombophlebitis | 6 (13) | 9 (13) | 0.96 (0.32 to 2.90) | |
Hard to treat area | 4 (9) | 6 (7) | 0.96 (0.26 to 3.61) | |
Large area | 4 (9) | 3 (4) | 2.02 (0.43 to 9.46) | |
Systemic features | 3 (6) | 3 (4) | 1.47 (0.29 to 7.66) | |
Young age | 0 (0) | 2 (3) | 0.28 (0.01 to 5.97) | |
Uncertain diagnosis | 0 (0) | 3 (4) | 0.20 (0.01 to 3.90) | |
Pain | 0 (0) | 2 (3) | 0.28 (0.01 to 5.97) | |
Not documented | 1 (2) | 3 (4) | 0.47 (0.05 to 4.67) |
*P values were calculated using Mann-Whitney U test where OR is not applicable.